Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127145072 | 12714507 | 2 | F | 2016 | 20160915 | 20160905 | 20160922 | PER | US-JAZZ-2016-US-008662 | JAZZ | 0.00 | F | Y | 0.00000 | 20160922 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127145072 | 12714507 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 127145072 | 12714507 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 127145072 | 12714507 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, FIRST DOSE | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 127145072 | 12714507 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, SECOND DOSE | 21196 | 3.75 | G | ORAL SOLUTION | |||||||
| 127145072 | 12714507 | 5 | SS | TOPAMAX | TOPIRAMATE | 1 | N | 0 | |||||||||||
| 127145072 | 12714507 | 6 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | U | 0 | |||||||||||
| 127145072 | 12714507 | 7 | C | ADDERALL XR | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | U | 0 | |||||||||||
| 127145072 | 12714507 | 8 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | U | 0 | |||||||||||
| 127145072 | 12714507 | 9 | C | BUPROPION HYDROCHLORIDE XL | BUPROPION HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127145072 | 12714507 | 10 | C | DILTIAZEM. | DILTIAZEM | 1 | U | 0 | |||||||||||
| 127145072 | 12714507 | 11 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | U | 0 | |||||||||||
| 127145072 | 12714507 | 12 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | U | 0 | |||||||||||
| 127145072 | 12714507 | 13 | C | MESTINON | PYRIDOSTIGMINE BROMIDE | 1 | U | 0 | |||||||||||
| 127145072 | 12714507 | 14 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127145072 | 12714507 | 1 | Narcolepsy |
| 127145072 | 12714507 | 5 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127145072 | 12714507 | Arthralgia | |
| 127145072 | 12714507 | Joint dislocation | |
| 127145072 | 12714507 | Migraine | |
| 127145072 | 12714507 | Temporomandibular joint syndrome | |
| 127145072 | 12714507 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127145072 | 12714507 | 1 | 201603 | 201603 | 0 | |
| 127145072 | 12714507 | 2 | 201603 | 201604 | 0 | |
| 127145072 | 12714507 | 3 | 201604 | 0 | ||
| 127145072 | 12714507 | 4 | 201604 | 0 |